Widely used GLP-1 receptor agonists, commonly prescribed for type 2 diabetes and obesity, may be associated with a small increase in colorectal cancer risk, according to a recent meta-analysis discussed by oncology expert David Kerr, MD, of the University of Oxford. The analysis pooled data…
Cedars-Sinai has received a $1.8 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to expand its…
Researchers from Washington University School of Medicine in St. Louis and Children’s Hospital of Philadelphia have shown that exhaled breath…
Gastroenterology reimbursement continues to erode under Medicare and commercial payment models, even as operating costs, staffing pressures and inflation rise.…
The U.S. Food and Drug Administration has issued a medical device early alert for certain lots of AXIOS Stent and…
DDW 2025
A new DDW 2025 study reveals a surprising truth: most post-polypectomy colorectal…
With 19 million more patients now eligible for colorectal cancer screening, the…
Headlines in GI
A growing number of parents are investing in tests, supplements, and lifestyle…
Endoluminal robotics may represent one of the most significant technological shifts in…
Thought Leadership
We have all seen the unfortunate headlines. Why are we seeing a rise of early-onset colorectal cancer and what can we do about it?…
A new generation of multi-cancer early detection (MCED) blood tests promises to…
As understanding of the brain–gut connection expands, behavioral health is becoming an…
Gastroenterology may be entering a new technological era that could fundamentally change…
ARTIFICIAL INTELLIGENCE (AI)
Artificial intelligence and its use in healthcare is a frontier that is both promising and potentially perilous. At ACG 2025,…
Tech & Innovation
Endoluminal robotics may represent one of the most significant technological shifts in gastroenterology since the advent of modern endoscopy. According to medtech strategist Steve Bell, robotic…
Editor's Picks
Widely used GLP-1 receptor agonists, commonly prescribed for type 2 diabetes and…
Business
Guardant Health has acquired MetaSight Diagnostics for $59 million upfront, with an…
Exponential Tech
Endoluminal robotics may represent one of the most significant technological shifts in…
Leadership
Becker’s Healthcare asked C-suite executives from hospitals, health systems, academic medical centers,…
Patient Trends
A new population-based study published in Clinical Gastroenterology and Hepatology evaluated the…
